Encompass Health (EHC) | Financial Analysis & Statements
Encompass Health Corporation Large-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
1.5B
Gross Profit
1.5B
95.82%
Operating Income
283.4M
18.35%
Net Income
203.1M
13.15%
EPS (Diluted)
$1.43
Balance Sheet Metrics
Total Assets
7.1B
Total Liabilities
3.8B
Shareholders Equity
3.3B
Debt to Equity
1.16
Cash Flow Metrics
Operating Cash Flow
331.5M
Free Cash Flow
116.7M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Encompass Health Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 5.9B | 5.4B | 4.8B | 4.3B | 4.0B |
| Cost of Goods Sold | 254.4M | 3.1B | 218.3M | 202.1M | 184.2M |
| Gross Profit | 5.7B | 2.2B | 4.6B | 4.1B | 3.8B |
| Gross Margin % | 95.7% | 41.6% | 95.5% | 95.4% | 95.4% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 3.4B | 266.5M | 2.9B | 2.6B | 2.4B |
| Other Operating Expenses | 888.7M | 802.6M | 719.1M | 670.4M | 595.9M |
| Total Operating Expenses | 4.3B | 1.1B | 3.6B | 3.3B | 3.0B |
| Operating Income | 1.1B | 864.5M | 731.8M | 630.2M | 659.4M |
| Operating Margin % | 17.7% | 16.1% | 15.2% | 14.5% | 16.4% |
| Non-Operating Items | |||||
| Interest Income | - | - | - | - | - |
| Interest Expense | 123.2M | 137.4M | 143.5M | 175.7M | 164.3M |
| Other Non-Operating Income | 23.1M | 22.5M | 18.9M | -3.7M | 9.9M |
| Pre-tax Income | 953.0M | 749.6M | 607.2M | 450.8M | 505.0M |
| Income Tax | 192.9M | 150.2M | 132.2M | 100.1M | 101.9M |
| Effective Tax Rate % | 20.2% | 20.0% | 21.8% | 22.2% | 20.2% |
| Net Income | 759.1M | 596.6M | 463.0M | 365.9M | 517.2M |
| Net Margin % | 12.8% | 11.1% | 9.6% | 8.4% | 12.9% |
| Key Metrics | |||||
| EBITDA | 1.4B | 1.2B | 1.0B | 871.5M | 889.9M |
| EPS (Basic) | $5.62 | $4.53 | $3.51 | $2.72 | $4.15 |
| EPS (Diluted) | $5.54 | $4.46 | $3.47 | $2.70 | $4.11 |
| Basic Shares Outstanding | 100500000 | 99900000 | 99500000 | 99200000 | 99000000 |
| Diluted Shares Outstanding | 100500000 | 99900000 | 99500000 | 99200000 | 99000000 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Encompass Health Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 72.2M | 85.4M | 69.1M | 21.8M | 49.4M |
| Short-term Investments | - | - | - | - | - |
| Accounts Receivable | 619.2M | 598.8M | 611.6M | 536.8M | 515.8M |
| Inventory | - | - | - | - | - |
| Other Current Assets | 129.9M | 122.7M | 91.5M | 92.1M | 114.9M |
| Total Current Assets | 905.9M | 886.9M | 841.8M | 717.2M | 921.4M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 212.6M | 203.7M | 208.5M | 212.5M | 193.7M |
| Goodwill | 2.9B | 2.9B | 2.8B | 2.8B | 2.6B |
| Intangible Assets | 308.3M | 298.8M | 278.2M | 282.3M | 158.4M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 243.7M | 219.2M | 191.6M | 222.1M | 1.8B |
| Total Non-Current Assets | 6.2B | 5.6B | 5.3B | 4.9B | 5.9B |
| Total Assets | 7.1B | 6.5B | 6.1B | 5.6B | 6.9B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 178.2M | 171.0M | 170.0M | 132.9M | 134.0M |
| Short-term Debt | 70.1M | 164.9M | 48.9M | 50.8M | 61.3M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 289.6M | 238.6M | 187.4M | 181.1M | 309.7M |
| Total Current Liabilities | 836.4M | 841.0M | 656.4M | 575.9M | 748.8M |
| Non-Current Liabilities | |||||
| Long-term Debt | 2.6B | 2.5B | 2.9B | 2.9B | 3.4B |
| Deferred Tax Liabilities | 126.8M | 105.2M | 87.0M | 83.0M | 23.3M |
| Other Non-Current Liabilities | 206.9M | 190.4M | 177.9M | 174.2M | 172.7M |
| Total Non-Current Liabilities | 3.0B | 2.8B | 3.1B | 3.2B | 3.7B |
| Total Liabilities | 3.8B | 3.7B | 3.8B | 3.8B | 4.5B |
| Equity | |||||
| Common Stock | 1.2M | 1.2M | 1.2M | 1.1M | 1.1M |
| Retained Earnings | 1.3B | 796.7M | 406.5M | 115.7M | 141.8M |
| Treasury Stock | 722.5M | 577.9M | 547.2M | 536.7M | 521.2M |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 3.3B | 2.8B | 2.3B | 1.9B | 2.4B |
| Key Metrics | |||||
| Total Debt | 2.7B | 2.7B | 2.9B | 3.0B | 3.5B |
| Working Capital | 69.5M | 45.9M | 185.4M | 141.3M | 172.6M |
Balance Sheet Composition
Encompass Health Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 760.1M | 599.4M | 475.0M | 350.7M | 403.1M |
| Depreciation & Amortization | 327.9M | 299.6M | 273.9M | 243.6M | 219.6M |
| Stock-Based Compensation | 56.5M | 48.3M | 50.6M | 29.2M | 29.1M |
| Working Capital Changes | 19.6M | 58.8M | 5.0M | -7.2M | -37.7M |
| Operating Cash Flow | 1.2B | 1.0B | 823.1M | 674.2M | 636.7M |
| Investing Activities | |||||
| Capital Expenditures | -736.4M | -642.5M | -583.1M | -584.1M | -545.7M |
| Acquisitions | - | - | - | 0 | -118.6M |
| Investment Purchases | - | - | - | - | - |
| Investment Sales | - | - | - | - | - |
| Investing Cash Flow | -764.6M | -653.3M | -602.8M | -623.5M | -665.7M |
| Financing Activities | |||||
| Share Repurchases | -158.0M | -31.1M | - | 0 | 0 |
| Dividends Paid | -71.1M | -62.8M | -60.4M | -99.0M | -112.2M |
| Debt Issuance | 210.0M | 95.0M | 80.0M | 251.8M | 300.0M |
| Debt Repayment | -239.0M | -337.0M | -163.3M | -750.0M | -359.1M |
| Financing Cash Flow | -431.2M | -330.6M | -197.2M | -660.8M | -329.9M |
| Free Cash Flow | 439.2M | 360.3M | 267.7M | 121.7M | 170.1M |
| Net Change in Cash | -3.3M | 57.3M | 23.1M | -610.1M | -358.9M |
Cash Flow Trend
Encompass Health Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
18.52
Forward P/E
15.86
Price to Book
4.21
Price to Sales
1.74
PEG Ratio
0.89
Profitability Ratios
Profit Margin
9.54%
Operating Margin
18.35%
Return on Equity
24.82%
Return on Assets
9.66%
Financial Health
Current Ratio
1.08
Debt to Equity
82.85
Beta
0.60
Per Share Data
EPS (TTM)
$5.55
Book Value per Share
$24.38
Revenue per Share
$59.06
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| EHC | 10.2B | 18.52 | 4.21 | 24.82% | 9.54% | 82.85 |
| HCA Healthcare | 106.0B | 16.86 | -38.44 | -244.82% | 8.97% | -17.57 |
| Tenet Healthcare | 16.5B | 12.17 | 3.88 | 27.02% | 6.60% | 160.79 |
| Universal Health | 11.1B | 7.84 | 1.52 | 21.33% | 8.57% | 69.73 |
| Ensign Group | 11.1B | 32.78 | 4.95 | 16.90% | 6.80% | 98.70 |
| DaVita | 10.0B | 16.32 | 9.13 | 64.85% | 5.47% | 1,111.35 |
Financial data is updated regularly. All figures are in the company's reporting currency.






